CHF Solutions Commences Manufacturing Transition of Aquadex FlexFlow

CHF Solutions (NASDAQ:CHFS) started the manufacturing transition of the Aquadex FlexFlow System to CHF Solutions’ facility in Minnesota.

As quoted in the press release:

The initial step, the transfer of the manufacturing assets, was completed last week.  These manufacturing assets were acquired from Baxter as part of the Aquadex acquisition that was completed on August 5, 2016.  The manufacturing assets had been retained by Baxter to manufacture and supply products to CHF Solutions under a Commercial Manufacturing and Supply Agreement that was signed at the time of the acquisition.  The company expects to begin manufacturing its Aquadex FlexFlow system products in the fourth quarter of 2017.

“I am very excited to achieve this important step in the evolution of CHF Solutions,” said John Erb, Chairman and Chief Executive Officer of CHF Solutions. “Bringing the manufacturing of the Aquadex FlexFlow system products in-house will give us greater control and flexibility in managing our operations.  Over time, we expect that this will result in improved gross margins as volumes and capacity utilization increases.”

Under the Commercial Manufacturing and Supply Agreement, CHF Solutions will continue to purchase raw materials and finished goods from an indirect subsidiary of Baxter until February 1, 2018.

Click here to read the full press release.

Get the Latest Medical Device Investing Stock Information

Get the latest information about companies associated with Medical Device Investing delivered directly to your inbox.

Medical Device

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time.

Comments

Leave a Reply